Please refer to attached pdf
Awaiting price reaction for this filing.
Ind-Swift Limited has received the certified copy of the final order from the NCLT Chandigarh Bench dated 28th July 2025, approving the Scheme of Arrangement for Amalgamation of Ind-Swift Limited (Transferor Company) with Ind-Swift Laboratories Limited (Transferee Company) and their respective shareholders and creditors. This is an update filed under SEBI LODR Regulation 30, following an earlier intimation dated 17th July 2025. The NCLT's final approval is a critical step toward completing the amalgamation between the two group companies.
Shareholders of Ind-Swift Limited stand to receive shares of Ind-Swift Laboratories Limited in exchange as per the approved swap ratio, effectively merging the two listed entities into one. The next steps typically involve the scheme becoming effective upon filing with the Registrar of Companies, after which the share swap and delisting/cancellation of Ind-Swift Limited's shares will take place — a significant corporate restructuring event for investors.